We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
America Movil
AMX
$78.1B
| $945K | 0.01% |
+60,850
| New | +$841K |
|
727
Advanced Drainage Systems
WMS
$10.9B
| $937K | 0.01% |
43,984
+24,185
| +122% | +$497K |
|
|
DVAX
728
DELISTED
Dynavax Technologies
DVAX
| $929K | 0.01% |
+48,285
| New | +$976K |
|
729
HUTCHMED
HCM
$1.89B
| $928K | 0.01% |
+70,314
| New | +$941K |
|
730
Globus Medical
GMED
$10.4B
| $920K | 0.01% |
+38,740
| New | +$947K |
|
731
Wayfair
W
$11.1B
| $909K | 0.01% |
21,038
-92,883
| -82% | -$3.85M |
|
|
JOYY
732
JOYY Inc
JOYY
$3.73B
| $904K | 0.01% |
14,681
-427
| -3% | -$24K |
|
|
CMCM
733
Cheetah Mobile
CMCM
$88.8M
| $903K | 0.01% |
+11,062
| New | +$853K |
|
734
Fresenius Medical Care
FMS
$13.2B
| $895K | 0.01% |
+20,309
| New | +$860K |
|
735
HubSpot
HUBS
$10.5B
| $887K | 0.01% |
+20,340
| New | +$875K |
|
|
LDRH
736
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $887K | 0.01% |
+34,812
| New | +$728K |
|
737
Aflac
AFL
$63.9B
| $883K | 0.01% |
+27,956
| New | +$830K |
|
|
RAI
738
DELISTED
Reynolds American Inc
RAI
| $879K | 0.01% |
17,469
-114
| -0.6% | -$5.6K |
|
739
Costco
COST
$415B
| $868K | 0.01% |
5,506
-6,785
| -55% | -$1.03M |
|
740
Dillards
DDS
$8.87B
| $865K | 0.01% |
+10,184
| New | +$763K |
|
|
YRD
741
Yiren Digital
YRD
$103M
| $864K | 0.01% |
74,201
-159,579
| -68% | -$1.08M |
|
742
AerCap
AER
$23.9B
| $860K | 0.01% |
+22,200
| New | +$764K |
|
743
NextEra Energy
NEE
$187B
| $860K | 0.01% |
+29,076
| New | +$816K |
|
|
VTAE
744
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $854K | 0.01% |
+128,747
| New | +$1.17M |
|
745
Anika Therapeutics
ANIK
$199M
| $853K | 0.01% |
19,081
+3,940
| +26% | +$160K |
|
|
XLNX
746
DELISTED
Xilinx Inc
XLNX
| $850K | 0.01% |
17,927
-4,894
| -21% | -$230K |
|
|
DRE
747
DELISTED
Duke Realty Corp.
DRE
| $845K | 0.01% |
+37,474
| New | +$771K |
|
748
Cirrus Logic
CRUS
$6.74B
| $843K | 0.01% |
+23,142
| New | +$750K |
|
|
EXAM
749
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $843K | 0.01% |
28,534
-19,344
| -40% | -$526K |
|
750
Olin
OLN
$2.64B
| $839K | 0.01% |
48,278
-35,226
| -42% | -$545K |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.